Treatment of GLP-1 for Diabetic Bariatric Patients
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
This study is for patients that are diabetic, and require insulin for glycemic control, and
going through the bariatric surgery process. This is a prospective study that is trying to
determine if the introduction of a semaglutide increases the remission rates of diabetes
post-operatively.